• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症恶病质与蛋白质代谢

Cancer cachexia and protein metabolism.

作者信息

Jeevanandam M, Horowitz G D, Lowry S F, Brennan M F

出版信息

Lancet. 1984 Jun 30;1(8392):1423-6. doi: 10.1016/s0140-6736(84)91929-9.

DOI:10.1016/s0140-6736(84)91929-9
PMID:6145877
Abstract

Metabolic abnormalities arising from malnutrition and malignancy are seen in patients with cancer cachexia. To discriminate between the effects of pure malnutrition and tumour-specific metabolic alterations, the kinetics of whole-body metabolism were determined in 7 untreated, malnourished cancer patients and in 11 patients with benign disease, also malnourished, by means of primed constant infusion of 15N-glycine. Patients in both groups received 500 kcal/day as 5% glucose solution without any nitrogen. Whole-body protein turnover was 32% and 35% higher in the cancer patients than in the non-cancer patients and starved normal subjects respectively. Similarly, the rate of protein synthesis was 35% and 54% higher in the cancer patients than in the non-cancer patients and starved normal subjects respectively. Our study supports the view that aberrations of host metabolism in patients with cancer cachexia are different from those in non-cancer patients suffering equivalent weight loss.

摘要

癌症恶病质患者会出现由营养不良和恶性肿瘤引起的代谢异常。为了区分单纯营养不良的影响和肿瘤特异性代谢改变,通过对7名未经治疗的营养不良癌症患者和11名同样营养不良的良性疾病患者进行15N-甘氨酸的单次注射持续输注,测定了全身代谢动力学。两组患者均接受500千卡/天的5%葡萄糖溶液,不含任何氮。癌症患者的全身蛋白质周转率分别比非癌症患者和饥饿的正常受试者高32%和35%。同样,癌症患者的蛋白质合成率分别比非癌症患者和饥饿的正常受试者高35%和54%。我们的研究支持这样一种观点,即癌症恶病质患者的宿主代谢异常与体重减轻相当的非癌症患者不同。

相似文献

1
Cancer cachexia and protein metabolism.癌症恶病质与蛋白质代谢
Lancet. 1984 Jun 30;1(8392):1423-6. doi: 10.1016/s0140-6736(84)91929-9.
2
Effect of total parenteral nutrition on whole body protein kinetics in cachectic patients with benign or malignant disease.
JPEN J Parenter Enteral Nutr. 1988 May-Jun;12(3):229-36. doi: 10.1177/0148607188012003229.
3
Cancer cachexia and the rate of whole body lipolysis in man.
Metabolism. 1986 Apr;35(4):304-10. doi: 10.1016/0026-0495(86)90145-9.
4
Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover.癌症恶病质对全身及骨骼肌蛋白质周转的影响。
Cancer. 1998 Jan 1;82(1):42-8.
5
Leucine kinetics in patients with benign disease, non-weight-losing cancer, and cancer cachexia: studies at the whole-body and tissue level and the response to nutritional support.良性疾病、非体重减轻型癌症及癌症恶病质患者的亮氨酸动力学:全身及组织水平研究以及对营养支持的反应
Surgery. 1991 Jan;109(1):37-50.
6
Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions.癌症恶病质中的蛋白质和氨基酸代谢:研究技术与治疗干预
Crit Rev Clin Lab Sci. 1993;30(3):223-72. doi: 10.3109/10408369309084669.
7
Hormonal and metabolic abnormalities in the malnourished cancer patient: effects on host-tumor interaction.
JPEN J Parenter Enteral Nutr. 1992 Nov-Dec;16(6 Suppl):60S-64S. doi: 10.1177/014860719201600605.
8
Nutrition, cancer, and aging: an annotated review. II. Cancer cachexia and aging.营养、癌症与衰老:一篇注释性综述。II. 癌症恶病质与衰老
J Am Geriatr Soc. 1986 Mar;34(3):219-28. doi: 10.1111/j.1532-5415.1986.tb04207.x.
9
Whole body protein synthesis and turnover in normal man and malnourished patients with and without known cancer.正常人和患有及未患有已知癌症的营养不良患者的全身蛋白质合成与更新。
Ann Surg. 1981 Aug;194(2):123-8. doi: 10.1097/00000658-198108000-00001.
10
Metabolic response of whole body and peripheral tissues to enteral nutrition in weight-losing cancer and noncancer patients.体重减轻的癌症患者和非癌症患者全身及外周组织对肠内营养的代谢反应。
Gastroenterology. 1983 Jul;85(1):92-9.

引用本文的文献

1
Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension.在健康受试者和肺动脉高压患者中,索他拉特塞的群体药代动力学建模。
CPT Pharmacometrics Syst Pharmacol. 2024 Aug;13(8):1380-1393. doi: 10.1002/psp4.13166. Epub 2024 May 29.
2
Cancer cachexia: biomarkers and the influence of age.癌症恶病质:生物标志物和年龄的影响。
Mol Oncol. 2024 Sep;18(9):2070-2086. doi: 10.1002/1878-0261.13590. Epub 2024 Feb 27.
3
Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
低血清白蛋白是侵袭性B细胞淋巴瘤老年患者的独立危险因素:德国高度恶性非霍奇金淋巴瘤研究组前瞻性试验结果
EJHaem. 2020 Jul 13;1(1):181-187. doi: 10.1002/jha2.61. eCollection 2020 Jul.
4
Advanced Lung Cancer Inflammation Index Predicts Survival Outcomes of Patients With Oral Cavity Cancer Following Curative Surgery.晚期肺癌炎症指数可预测口腔癌患者根治性手术后的生存结局。
Front Oncol. 2021 Sep 30;11:609314. doi: 10.3389/fonc.2021.609314. eCollection 2021.
5
Opportunities for using in silico-based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors.基于计算机模拟的单克隆抗体免疫检查点抑制剂延长给药方案的应用机会。
Br J Clin Pharmacol. 2020 Sep;86(9):1769-1777. doi: 10.1111/bcp.14369. Epub 2020 Jun 11.
6
Understanding Inter-Individual Variability in Monoclonal Antibody Disposition.理解单克隆抗体处置过程中的个体间差异。
Antibodies (Basel). 2019 Dec 4;8(4):56. doi: 10.3390/antib8040056.
7
GSK3β inhibits epithelial-mesenchymal transition the Wnt/β-catenin and PI3K/Akt pathways.糖原合成酶激酶3β通过Wnt/β-连环蛋白和磷脂酰肌醇-3-激酶/蛋白激酶B信号通路抑制上皮-间质转化。
Int J Ophthalmol. 2018 Jul 18;11(7):1120-1128. doi: 10.18240/ijo.2018.07.08. eCollection 2018.
8
Glomerular hyperfiltration in children with cancer: prevalence and a hypothesis.癌症患儿的肾小球高滤过:患病率及一种假说
Pediatr Radiol. 2017 Feb;47(2):221-226. doi: 10.1007/s00247-016-3733-5. Epub 2016 Nov 3.
9
Cancer cachexia: impact, mechanisms and emerging treatments.癌症恶病质:影响、机制和新的治疗方法。
J Cachexia Sarcopenia Muscle. 2013 Jun;4(2):95-109. doi: 10.1007/s13539-012-0087-1. Epub 2012 Oct 25.
10
Non-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19.非手术肿瘤学——肠外营养指南,第19章。
Ger Med Sci. 2009 Nov 18;7:Doc09. doi: 10.3205/000068.